Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

Similar articles for PubMed (Select 21130662)

1.

Functional in vivo imaging of cysteine cathepsin activity in murine model of inflammation.

Caglič D, Globisch A, Kindermann M, Lim NH, Jeske V, Juretschke HP, Bartnik E, Weithmann KU, Nagase H, Turk B, Wendt KU.

Bioorg Med Chem. 2011 Feb 1;19(3):1055-61. doi: 10.1016/j.bmc.2010.10.028. Epub 2010 Oct 19.

PMID:
21130662
2.

Carbobenzoxy-capped Phe-Lys(BODIPY TMR-X-acyloxymethyl ketone(QSY7).

Shan L.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2010 May 19 [updated 2010 May 25].

3.

Carbobenzoxy-capped Phe-Lys(Cy5)-acyloxymethyl ketone.

Shan L.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2010 May 09 [updated 2010 May 25].

4.

Noninvasive quantitative tomography of the therapeutic response to dexamethasone in ovalbumin-induced murine asthma.

Korideck H, Peterson JD.

J Pharmacol Exp Ther. 2009 Jun;329(3):882-9. doi: 10.1124/jpet.108.147579. Epub 2009 Mar 17.

5.

Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes.

Blum G, von Degenfeld G, Merchant MJ, Blau HM, Bogyo M.

Nat Chem Biol. 2007 Oct;3(10):668-77. Epub 2007 Sep 9.

PMID:
17828252
6.

Selective targeting of lysosomal cysteine proteases with radiolabeled electrophilic substrate analogs.

Bogyo M, Verhelst S, Bellingard-Dubouchaud V, Toba S, Greenbaum D.

Chem Biol. 2000 Jan;7(1):27-38.

PMID:
10662686
7.

Inhibition of the cathepsin cysteine proteases B and K by square-planar cycloaurated gold(III) compounds and investigation of their anti-cancer activity.

Zhu Y, Cameron BR, Mosi R, Anastassov V, Cox J, Qin L, Santucci Z, Metz M, Skerlj RT, Fricker SP.

J Inorg Biochem. 2011 May;105(5):754-62. doi: 10.1016/j.jinorgbio.2011.01.012. Epub 2011 Jan 26.

PMID:
21481817
8.

Cysteine cathepsin proteases as pharmacological targets in cancer.

Palermo C, Joyce JA.

Trends Pharmacol Sci. 2008 Jan;29(1):22-8. Epub 2007 Nov 26. Review.

PMID:
18037508
9.

Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensor.

Jaffer FA, Kim DE, Quinti L, Tung CH, Aikawa E, Pande AN, Kohler RH, Shi GP, Libby P, Weissleder R.

Circulation. 2007 May 1;115(17):2292-8. Epub 2007 Apr 9.

10.
11.

Cathepsins X and B display distinct activity profiles that can be exploited for inhibitor design.

Ménard R, Therrien C, Lachance P, Sulea T, Qo H, Alvarez-Hernandez AD, Roush WR.

Biol Chem. 2001 May;382(5):839-45.

PMID:
11517939
12.

An activity-based probe for the determination of cysteine cathepsin protease activities in whole cells.

Falgueyret JP, Black WC, Cromlish W, Desmarais S, Lamontagne S, Mellon C, Riendeau D, Rodan S, Tawa P, Wesolowski G, Bass KE, Venkatraman S, Percival MD.

Anal Biochem. 2004 Dec 15;335(2):218-27. Erratum in: Anal Biochem. 2005 May 15;340(2):380.

PMID:
15556560
13.
14.

Design of potent, selective, and orally bioavailable inhibitors of cysteine protease cathepsin k.

Tavares FX, Boncek V, Deaton DN, Hassell AM, Long ST, Miller AB, Payne AA, Miller LR, Shewchuk LM, Wells-Knecht K, Willard DH Jr, Wright LL, Zhou HQ.

J Med Chem. 2004 Jan 29;47(3):588-99.

PMID:
14736240
15.

Use of molecular imaging to quantify response to IKK-2 inhibitor treatment in murine arthritis.

Izmailova ES, Paz N, Alencar H, Chun M, Schopf L, Hepperle M, Lane JH, Harriman G, Xu Y, Ocain T, Weissleder R, Mahmood U, Healy AM, Jaffee B.

Arthritis Rheum. 2007 Jan;56(1):117-28.

PMID:
17195214
16.

Design of cathepsin K inhibitors for osteoporosis.

Deaton DN, Tavares FX.

Curr Top Med Chem. 2005;5(16):1639-75. Review.

PMID:
16375747
17.

Highly sensitive detection of early-stage pancreatic cancer by multimodal near-infrared molecular imaging in living mice.

von Burstin J, Eser S, Seidler B, Meining A, Bajbouj M, Mages J, Lang R, Kind AJ, Schnieke AE, Schmid RM, Schneider G, Saur D.

Int J Cancer. 2008 Nov 1;123(9):2138-47. doi: 10.1002/ijc.23780.

PMID:
18709639
18.

Improved quenched fluorescent probe for imaging of cysteine cathepsin activity.

Verdoes M, Oresic Bender K, Segal E, van der Linden WA, Syed S, Withana NP, Sanman LE, Bogyo M.

J Am Chem Soc. 2013 Oct 2;135(39):14726-30. doi: 10.1021/ja4056068. Epub 2013 Sep 19.

19.

Anti-inflammatory effects of orally ingested lactoferrin and glycine in different zymosan-induced inflammation models: evidence for synergistic activity.

Hartog A, Leenders I, van der Kraan PM, Garssen J.

Int Immunopharmacol. 2007 Dec 15;7(13):1784-92. Epub 2007 Oct 8.

PMID:
17996689
20.

Discovery of selective and nonpeptidic cathepsin S inhibitors.

Irie O, Ehara T, Iwasaki A, Yokokawa F, Sakaki J, Hirao H, Kanazawa T, Teno N, Horiuchi M, Umemura I, Gunji H, Masuya K, Hitomi Y, Iwasaki G, Nonomura K, Tanabe K, Fukaya H, Kosaka T, Snell CR, Hallett A.

Bioorg Med Chem Lett. 2008 Jul 15;18(14):3959-62. doi: 10.1016/j.bmcl.2008.06.009. Epub 2008 Jun 10.

PMID:
18572405
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk